BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9086506)

  • 1. Food and Drug Administration Proposed Guidelines for Neurotoxicological Testing of Food Chemicals.
    Sobotka TJ; Ekelman KB; Slikker W; Raffaele K; Hattan DG
    Neurotoxicology; 1996; 17(3-4):825-36. PubMed ID: 9086506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food and Drug Administration proposed testing guidelines for developmental toxicity studies. Revision Committee. FDA Guidelines for Developmental Toxicity and Reproduction, Food and Drug Administration.
    Collins TF; Sprando RL; Shackelford ME; Hansen DK; Welsh JJ
    Regul Toxicol Pharmacol; 1999 Aug; 30(1):39-44. PubMed ID: 10464045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food and Drug Administration proposed testing guidelines for reproduction studies. Revision Committee. FDA Guidelines for Developmental Toxicity and Reproduction, Food and Drug Administration.
    Collins TF; Sprando RL; Shackelford ME; Hansen DK; Welsh JJ
    Regul Toxicol Pharmacol; 1999 Aug; 30(1):29-38. PubMed ID: 10464044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution and current status of neurotoxicity risk assessment.
    Tilson HA
    Drug Metab Rev; 1996; 28(1-2):121-39. PubMed ID: 8744593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxicology risk assessment guidelines: developmental neurotoxicology.
    Tilson HA
    Neurotoxicology; 2000; 21(1-2):189-94. PubMed ID: 10794399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-level chemical sensitivity: a perspective from behavioral toxicology.
    Weiss B
    Toxicol Ind Health; 1994; 10(4-5):605-17. PubMed ID: 7778118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategy for genotoxicity testing--metabolic considerations.
    Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S;
    Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisions to the FDA's Redbook guidelines for toxicity testing: neurotoxicity.
    Sobotka TJ
    Crit Rev Food Sci Nutr; 1992; 32(2):165-71. PubMed ID: 1515045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
    Brent RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of anesthetic agents in neonates and young children.
    Mellon RD; Simone AF; Rappaport BA
    Anesth Analg; 2007 Mar; 104(3):509-20. PubMed ID: 17312200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An enhanced tiered toxicity testing framework with triggers for assessing hazards and risks of commodity chemicals.
    Plunkett LM; Kaplan AM; Becker RA
    Regul Toxicol Pharmacol; 2010 Dec; 58(3):382-94. PubMed ID: 20709129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The concept of multispecies testing in industrial toxicology.
    Zbinden G
    Regul Toxicol Pharmacol; 1993 Feb; 17(1):85-94. PubMed ID: 8441831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA toxicity databases and real-time data entry.
    Arvidson KB
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):17-9. PubMed ID: 18656494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying food proteins with allergenic potential: evolution of approaches to safety assessment and research to provide additional tools.
    Ladics GS; Selgrade MK
    Regul Toxicol Pharmacol; 2009 Aug; 54(3 Suppl):S2-6. PubMed ID: 19028539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegenerative memory disorders: a potential role of environmental toxins.
    Caban-Holt A; Mattingly M; Cooper G; Schmitt FA
    Neurol Clin; 2005 May; 23(2):485-521. PubMed ID: 15757794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the neurotoxic potential of chemicals--a multidisciplinary approach.
    Becking GC; Boyes WK; Damstra T; MacPhail RC
    Environ Res; 1993 Apr; 61(1):164-75. PubMed ID: 8472671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.